tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market
MBRX
Moleculin Biotech
RESEARCH TOOLSreports
Want to see MBRX full AI Analyst Report?

Moleculin Biotech (MBRX) Stock News & Sentiment

1,952 Followers
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress and Safety Profile Support Unchanged $22 Price Target
Premium
Ratings
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress and Safety Profile Support Unchanged $22 Price Target
7d ago
MBRX
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target
Premium
Ratings
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target
8d ago
MBRX
Moleculin Nears First Unblinding in Pivotal MIRACLE Trial
Premium
Company Announcements
Moleculin Nears First Unblinding in Pivotal MIRACLE Trial
9d ago
8K
MBRX
Moleculin highlights favorable cardiac safety data for Annamycin
Premium
Company Announcements
Moleculin highlights favorable cardiac safety data for Annamycin
10d ago
8K
MBRX
Moleculin Secures New Hong Kong Patent for Annamycin
Premium
Company Announcements
Moleculin Secures New Hong Kong Patent for Annamycin
14d ago
8K
MBRX
Moleculin Highlights Promising Preclinical Data for L-ANN
Premium
Company Announcements
Moleculin Highlights Promising Preclinical Data for L-ANN
29d ago
8K
MBRX
Moleculin Biotech Stockholders Approve Warrant Share Issuance
Premium
Company Announcements
Moleculin Biotech Stockholders Approve Warrant Share Issuance
1M ago
8K
MBRX
More MBRX News >

MBRX News on the Web

What Does GF Score 27/100 Say About Moleculin Biotech (MBRX) After Q1 2026 Earnings? EPS N/A, ...
GuruFocus News
Neutral
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress and Safety Profile Support Unchanged $22 Price Target
TipRanks News
Bullish
Buy Rating Reiterated on Moleculin Biotech as MIRACLE Trial Progress Supports Unchanged $10 Price Target
TipRanks News
Bullish
Moleculin Biotech expects first unblinding of MIRACLE trial data by June 30
TipRanks News
Bullish
Moleculin Nears First Unblinding in Pivotal MIRACLE Trial
TipRanks News
Neutral
Moleculin announces publication on cardiac safety profiloe of annamycin
TipRanks News
Bullish
Moleculin highlights favorable cardiac safety data for Annamycin
TipRanks News
Neutral
Moleculin Biotech issued liposomal Annamycin patent in Hong Kong
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MBRX’s Media Buzz Sentiment?
Currently, no data Available
What is MBRX’s weekly average amount of articles?
In an average week, 2.75 articles about MBRX are published.
    What is MBRX’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    GOSSGossamer Bio
    RLAYRelay Therapeutics
    ROIVRoivant Sciences
    ILAIsland Pharmaceuticals Ltd
    JUNSJupiter Neurosciences, Inc.
    Showing the stocks with the most bullish news sentiment over the past week